It is referred to as a qualified therapy mainly because it particularly targets the CD38 which might be overexpressed over the multiple myeloma cells. Daratumumab is from a class of medicines known as CD38 monoclonal antibodies. Overview the full client medication information and talk about this information and any issues https://troyjcreg.rimmablog.com/34152375/saxenda-weight-loss-injection-nhs-options